ScholarIQanswers from OpenAlex & ORCID
Charles L. Bowden
ResearcherPublications, citations & collaboration network
Charles L. Bowden is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Charles L. Bowden have?
ScholarIQindexed works
Charles L. Bowden has 498 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Charles L. Bowden have?
ScholarIQcitation count
Charles L. Bowden has 32,217 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Charles L. Bowden?
ScholarIQh-index
Charles L. Bowden has an h-index of 85 in OpenAlex.
What is the i10-index of Charles L. Bowden?
ScholarIQi10-index
Charles L. Bowden has an i10-index of 298 in OpenAlex.
What is the OpenAlex record for Charles L. Bowden?
ScholarIQopenalex
The OpenAlex for Charles L. Bowden is on the source record.
What are the most-cited papers on Charles L. Bowden?
ScholarIQmost cited works
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Gary S. Sachs, Andrew A. Nierenberg, Joseph R. Calabrese, Lauren B. Marangell, Stephen R. Wisniewski, L. Gyulai, Edward S. Friedman, Charles L. Bowden, Mark D. Fossey, Michael J. Ostacher, Terence A. Ketter, Jayendra K. Patel, Péter Hauser, Daniel Rapport, James M. Martinez, Michael H. Allen, David J. Miklowitz, Michael W. Otto, Ellen B. Dennehy, Michael E. Thase
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Mauricio Tohen, Eduard Vieta, Joseph R. Calabrese, Terence A. Ketter, Gary Sachs, Charles L. Bowden, Philip B. Mitchell, Franca Centorrino, Richard C. Risser, Robert W. Baker, Angela R. Evans, Karin Beymer, Sanjay Dubé, Gary D. Tollefson, Alan Breier
Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Roy H. Perlis, Sachiko Miyahara, Lauren B. Marangell, Stephen R. Wisniewski, Michael J. Ostacher, Melissa P. DelBello, Charles L. Bowden, Gary S Sachs, Andrew A. Nierenberg
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Isabella Pacchiarotti, David J. Bond, Ross J. Baldessarini, Willem A. Nolen, Heinz Grunze, Rasmus Wentzer Licht, Robert M. Post, Michael Berk, Guy M. Goodwin, Gary S. Sachs, Leonardo Tondo, Robert L. Findling, Eric A. Youngstrom, Mauricio Tohen, Juan Undurraga, Ana González‐Pinto, Joseph F. Goldberg, Ayşegül Yıldız, Lori L. Altshuler, Joseph R. Calabrese, Philip B. Mitchell, Michael E. Thase, Athanasios Koukopoulos, Francesc Colom, Mark A. Frye, Gin S. Malhi, Konstantinos Ν. Fountoulakis, Gustavo Vázquez, Roy H. Perlis, Terence A. Ketter, Frederick Cassidy, Hagop S. Akiskal, Jean-Michel Azorin, Marc Valentí, Diego Hidalgo‐Mazzei, Beny Lafer, Tadafumi Kato, Lorenzo Mazzarini, Anabel Martínez‐Arán, Gordon Parker, Daniel Souery, Ayşegül Özerdem, Susan L. McElroy, Paolo Girardi, Michael Bauer, Lakshmi N. Yatham, Carlos A. Zarate, Andrew A. Nierenberg, Boris Birmaher, Shigenobu Kanba, Rif S. El‐Mallakh, Alessandro Serretti, Zoltán Rihmer, Allan H. Young, Georgios D. Kotzalidis, Glenda MacQueen, Charles L. Bowden, S. Nassir Ghaemi, Carlos López‐Jaramillo, Janusz Rybakowski, Kyooseob Ha, Giulio Perugi, Siegfried Kasper, Jay D. Amsterdam, Robert M. A. Hirschfeld, Flávio Kapczinski, Eduard Vieta
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Gary S Sachs, Michael E. Thase, Michael W. Otto, Mark S. Bauer, David J. Miklowitz, Stephen R. Wisniewski, Philip W. Lavori, Barry D. Lebowitz, Mathew Rudorfer, Ellen Frank, Andrew A. Nierenberg, Maurizio Fava, Charles L. Bowden, Terence A. Ketter, Lauren B. Marangell, Joseph R. Calabrese, David J. Kupfer, Jerrold F. Rosenbaum